Fujian Acetron New Materials Balance Sheet Health
Financial Health criteria checks 2/6
Fujian Acetron New Materials has a total shareholder equity of CN¥783.7M and total debt of CN¥776.2M, which brings its debt-to-equity ratio to 99%. Its total assets and total liabilities are CN¥1.8B and CN¥1.1B respectively. Fujian Acetron New Materials's EBIT is CN¥23.7M making its interest coverage ratio 1.1. It has cash and short-term investments of CN¥294.4M.
Key information
99.0%
Debt to equity ratio
CN¥776.24m
Debt
| Interest coverage ratio | 1.1x |
| Cash | CN¥294.44m |
| Equity | CN¥783.74m |
| Total liabilities | CN¥1.05b |
| Total assets | CN¥1.84b |
Recent financial health updates
Recent updates
Does Fujian Acetron New Materials (SZSE:300706) Have A Healthy Balance Sheet?
Dec 24
Fujian Acetron New Materials Co., Ltd. (SZSE:300706) Looks Just Right With A 42% Price Jump
Oct 14Be Wary Of Fujian Acetron New Materials (SZSE:300706) And Its Returns On Capital
Sep 30Weak Statutory Earnings May Not Tell The Whole Story For Fujian Acetron New Materials (SZSE:300706)
Sep 05Fujian Acetron New Materials Co., Ltd.'s (SZSE:300706) 30% Share Price Surge Not Quite Adding Up
Mar 06Financial Position Analysis
Short Term Liabilities: 300706's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥962.2M).
Long Term Liabilities: 300706's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥90.0M).
Debt to Equity History and Analysis
Debt Level: 300706's net debt to equity ratio (61.5%) is considered high.
Reducing Debt: 300706's debt to equity ratio has increased from 42% to 99% over the past 5 years.
Debt Coverage: 300706's debt is not well covered by operating cash flow (10.1%).
Interest Coverage: 300706's interest payments on its debt are not well covered by EBIT (1.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/08 05:24 |
| End of Day Share Price | 2025/01/08 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Fujian Acetron New Materials Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gen He | Everbright Securities Co. Ltd. |
| Zhiqiang Ren | Industrial Securities Co. Ltd. |